Ultragenyx Pharmaceutical
RARE
#3693
Rank
โ‚น315.22 B
Marketcap
โ‚น3,267
Share price
-0.29%
Change (1 day)
-21.20%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น315.22 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of โ‚น315.22 Billion. This makes Ultragenyx Pharmaceutical the world's 3693th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น315.22 B-8.36%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น316.14 Billion
by Nasdaq info icon info icon
โ‚น316.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น921.85 B 192.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น275.93 B-12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น86.37 B-72.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น44.24 B-85.96%๐Ÿ‡บ๐Ÿ‡ธ USA